🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMarketplace & ListingsHas anyone dealt with compounded tirzepatide availability tracker?

Has anyone dealt with compounded tirzepatide availability tracker?

TomFromTexas Mon, Nov 3, 2025 at 7:30 PM 6 replies 1,043 viewsPage 1 of 2
This thread is more than 7 months old. Information may be outdated. Consider searching for more recent discussions.
TomFromTexas
Member
645
2,890
May 2024
Austin, TX
Nov 3, 2025 at 7:30 PM#1

This is the version of the explanation I wish somebody had given me, written down before I forget what confused me. It is about compounded supply, and it is deliberately narrow — everything I am not confident about is marked as such.

What is actually established

They are two different exemptions from the same federal requirements and they buy different things. A 503A pharmacy is regulated primarily by the state board, needs a patient-specific prescription, is exempt from CGMP, and may use a bulk substance that has a USP monograph, is a component of an approved drug, or appears on the 503A bulks list — three independent doorways. A 503B outsourcing facility registers with the FDA, is inspected on a risk basis, must comply with CGMP, may compound for office stock without a patient-specific prescription, and has one doorway to a permitted bulk substance: the 503B bulks list, or the drug shortage list.

The condition it depends on

The enforcement dates were staggered by category — 503A first, 503B a few weeks later — because outsourcing facilities have manufactured inventory and clinic contracts to unwind while a 503A makes to order.

The practical version

Two things anyone can check: a state licence number for a 503A, and an FDA outsourcing-facility registration for a 503B. Both are publicly searchable, and a pharmacy unwilling to give you either has answered the question.

What I am not sure about

What I am after is what actually distinguishes 503A from 503B, in terms of what each may make and from what starting material. If the honest answer is that nobody knows, that is a useful answer and I would rather have it.

— TomFromTexas · corrections welcome and will be edited into this post with credit
45 15PharmD_Rodriguez, julia.endo, JessicaM_2024 and 42 others
Reply Quote Save Share Report
Dr.ReproEndo
Senior Member
1,890
8,901
Jan 2024
Scottsdale, AZ
Nov 3, 2025 at 7:49 PM#2
TomFromTexas said:
They are two different exemptions from the same federal requirements and they buy different things.

That is correct as far as it goes, and here is where it stops going. Resolution therefore closed the doors unevenly, and the asymmetry follows from the bulks lists. For 503B the shortage clause was the only route to these molecules, so that route shut completely. A 503A pharmacy can still argue a doorway via "component of an approved drug" — but only for the substance in the form present in the approved product, which is exactly where the base-versus-salt argument lives, and it does nothing about the copy restriction, which came back into force on resolution.

Correct me if the detail matters more than I have assumed.

Last edited: Nov 3, 2025 at 8:49 PM
44 14andrew_nyc, Dr.EndoEP, GraceAZ_72 and 41 others
Reply Quote Save Share Report
Dr.RaviCardio
VIP Member
2,890
15,678
Jan 2024
New York, NY
Nov 3, 2025 at 8:08 PM#3
TomFromTexas said:
They are two different exemptions from the same federal requirements and they buy different things.

I read this differently from TomFromTexas, on substance rather than tone. A research-chemical supplier selling lyophilised powder labelled research use only is not compounding and is not claiming to. It is a different legal universe with no pharmacy oversight, no patient relationship and no content guarantee, and conflating the two in these threads helps nobody.

Ask again with the specifics and you will get a better answer than this one.

43 13mark_tokyo, hans_munich, jason_sac26 and 40 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
newstart_MO
New Member
12
45
Feb 2026
Springfield, MO
Nov 3, 2025 at 8:27 PM#4

This one has a reasonably settled answer, so here it is. The shortage clause is the answer to the second question and it is a subtraction rather than an addition. Both exemptions forbid compounding something that is essentially a copy of a commercially available approved product. A product FDA has listed as in shortage is not treated as commercially available, so listing removed the objection that otherwise blocked compounding. It never created a permission; it withdrew a prohibition, which is why it evaporated the moment the supply fact changed.

42 12TrialNerd_Beth, HPLC_Greg, LibrarianMeg and 39 others
Reply Quote Save Share Report
MikeKY_noInsulin
Member
267
1,234
Oct 2024
Louisville, KY
Nov 3, 2025 at 10:08 PM#5
Dr.ReproEndo said:
Resolution therefore closed the doors unevenly, and the asymmetry follows from the bulks lists.

True, though the ladder is longer and that is not a neutral detail — six dose steps means six opportunities to stall on the way up, and plenty of people never reach the dose the headline number came from.

41 11bbq_ray_KC, oliver_london, tane_welly and 38 others
Reply Quote Save Share Report

Similar Threads

Price comparison: compounded semaglutide — June 202622 replies
Telehealth provider directory — updated quarterly5 replies
Group buy discussion — is it worth organizing?3 replies
Bacteriostatic water sourcing guide — verified suppliers3 replies
Compounded semaglutide price tracker — updated weekly19 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register